Unique ID issued by UMIN | UMIN000014808 |
---|---|
Receipt number | R000017214 |
Scientific Title | The research on safety of traditional Japanese herbal (Kampo) medicine, daiobotanpito in the treatment of acute diverticulitis: an intervention trial |
Date of disclosure of the study information | 2014/08/09 |
Last modified on | 2017/04/05 07:23:03 |
The research on safety of traditional Japanese herbal (Kampo) medicine, daiobotanpito in the treatment of acute diverticulitis: an intervention trial
Safety of daiobotanpito in the treatment of acute diverticulitis
The research on safety of traditional Japanese herbal (Kampo) medicine, daiobotanpito in the treatment of acute diverticulitis: an intervention trial
Safety of daiobotanpito in the treatment of acute diverticulitis
Japan |
Diverticulitis
Gastroenterology | Infectious disease |
Others
NO
This study aims to evaluate of safety of daiobotanpito in the treatment of acute diverticulitis with antibiotics and fast.
Safety
Confirmatory
Pragmatic
Phase II,III
Adverse events (type, frequency, and time of emergence)
Duration of abdominal pain
Febrile period, and NSAID use
CRP and WBC
Size of abscess
Frequency of defecation
Aggravation
daiobotampito use
Antibiotics use
Timing to resume meal
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
daiobotanpito use
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1. Patients with diverticulitis
2. Patients who have signed consent to participate in this research
1. High probability to perforate.
2. Diarrhea or soft stool.
3. Chronic appetite loss, abdominal pain or diarrhea.
4. Too friable.
5. Insulin use.
6. Immuno-compromised host.
7. Pregnant or puerperal.
8. Kidney disease (eGFR < 20 ml/min/1.73m^2).
9. Allergy to daiobotampito.
10. Experience to jpin in this trial before.
11. No abdominal pain and fever.
12. Doctor's diagnosis as inappropriate.
10
1st name | |
Middle name | |
Last name | Nakazawa, Atsushi |
Tokyo Saiseikai Central Hospital
Gastrointestinal Medcine
Mita 1-4-17, Minato-ku, Tokyo, Japan 108-0073
03-3451-8211
anakaza@b-star.jp
1st name | |
Middle name | |
Last name | Koike, Hiroshi |
Keio University School of Medicine
Center for Kampo Medicine
Shinanomachi 35, Shinjyuku-ku, Tokyo, Japan 160-8582
03-5366-3824
koike-h@umin.ac.jp
Gastrointestinal Medcine, Tokyo Saiseikai Central Hospital
Center for Kampo Medicine, Keio University School of Medicine
Self funding
NO
2014 | Year | 08 | Month | 09 | Day |
Published
http://online.liebertpub.com/doi/abs/10.1089/acm.2016.0367?journalCode=acm
Daiobotampito is a safe treatment option for acute, early stage diverticulitis.
Completed
2014 | Year | 07 | Month | 01 | Day |
2014 | Year | 08 | Month | 11 | Day |
2014 | Year | 08 | Month | 09 | Day |
2017 | Year | 04 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017214
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |